Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.

@article{ShapiroWright2010SentinelLN,
  title={Sentinel lymph node biopsy and management of the axilla in ductal carcinoma in situ.},
  author={Hilary M Shapiro-Wright and Thomas B. Julian},
  journal={Journal of the National Cancer Institute. Monographs},
  year={2010},
  volume={2010 41},
  pages={145-9}
}
Ductal carcinoma in situ (DCIS) of the breast historically has been a disease detected by physical examination, diagnosed by open surgical biopsy, and treated by mastectomy and axillary dissection. It is now increasingly detected by screening mammography, diagnosed by needle core biopsy, and treated by lumpectomy, with axillary dissection having been abandoned and sentinel node biopsy being used in axillary staging. However, outcomes related to sentinel node biopsy in DCIS have not been… CONTINUE READING